Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - Blake Insomnia Therapeutics, Inc. | bkit_10q.htm |
EX-31.1 - CERTIFICATION - Blake Insomnia Therapeutics, Inc. | bkit_ex31.htm |
EXHIBIT 32.1
Section 1350 Certifications
Blake Insomnia Therapeutics, Inc.
Pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsection (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Blake Insomnia Therapeutics, Inc., a Nevada corporation (the "Company"), does hereby certify that:
The Quarterly Report on Form 10-Q for the quarter ended November 30, 2016 (the "Form 10-Q") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: January 17, 2017 | By: | /s/ BIRGER JAN OLSEN | |
|
| BIRGER JAN OLSEN Principal Executive Officer and Principal Financial Officer |